Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
3,568
Funds Holding Change
+37
Funds Holding Growth
+1%
Value
$1.11T
Holding in Top 10
1,242
Top 10 Change
-180
Top 10 Growth
-13%
Value Growth
+3%
New
157
Increased
1,535
Reduced
1,677
Closed
72
Capital Inflow
$35B
Capital Outflow
$33.7B
Net Capital Flow
+$1.32B
Capital Flow Change
-$1.85B
Calls
$12.9B
Puts
$14.2B
Net Calls
-$1.23B
Put/Call Ratio
1.09